Taking into consideration these findings, the improvement of ABCG1-efflux induced by PCSK9-i treatment could ameliorate the inflammatory status that characterized subjects with a high cholesterol burden, such as FH (Bahrami et al., 2020). This evidence concerns the gene PCSK9 and familial hyperaldosteronism.